Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

farnesylamine

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Farnesol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Metabolic Basis of Visual Cycle Inhibition by Retinoid and Nonretinoid Compounds in the Vertebrate Retina*
In vertebrate retinal photoreceptors, the absorption of light by rhodopsin leads to photoisomerization of 11-cis-retinal to its… Expand
  • figure 1
  • figure 4
  • figure 3
  • figure 5
  • figure 6
2006
2006
Famesylamine: An inhibitor of famesylation and growth ofras-transformed cells
Farnesylamine, an analogue of farnesol, was shown to inhibit growth of PAP2 cells (ras-transformed NIH 3T3 cells) in a dose… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2004
2004
Oxidative stress-dependent inhibition of yeast cell growth by farnesylamine and its possible relation to amine oxidase in the mitochondrial fraction.
Among various analogs of the isoprenoid farnesol (FOH), farnesylamine (FNH2) inhibited the growth of the budding yeast… Expand
2003
2003
Farnesylamine from the ant Monomorium fieldi Forel.
(2E)- and (2Z)-Farnesylamine were detected in the extracts of the myrmicine ant Monomorium fieldi Forel from Australia. Their… Expand
2002
2002
[Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
  • Y. Mizukami
  • [Hokkaido igaku zasshi] The Hokkaido journal of…
  • 2002
    • Corpus ID: 25864152
We have previously shown that farnesylamine which acts as a farnesyltransferase inhibitor (FTI) induces apoptosis in human… Expand
2001
2001
Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells.
Farnesyltransferase inhibitors (FTIs) represent a novel class of anticancer drugs and are now in clinical trial. We have… Expand
1998
1998
Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki‐ras–transformed fibroblasts
Farnesyl protein transferase (FPTase) catalyses the post‐translational modification of proteins by a farnesyl pyrophosphate. One… Expand
1994
1994
Effects of long-chain fatty amines on the growth of ras-transformed NIH 3T3 cells.
A number of aliphatic primary amines were tested for their effects on the growth of ras-transformed NIH 3T3 cells (PAP2 cells… Expand
1993
1993
Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
Farnesylamine, an analogue of farnesol, was shown to inhibit growth of PAP2 cells (ras-transformed NIH 3T3 cells) in a dose… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE